Prognostic and predictive value of tumor in early breast cancer

被引:53
作者
Criscitiello, Carmen [1 ]
Esposito, Angela [1 ]
Trapani, Dario [1 ]
Curigliano, Giuseppe [1 ]
机构
[1] Ist Europeo Oncol, Via Ripamonti 435, I-20141 Milan, Italy
关键词
Breast cancer; Tumor infiltrating lymphocytes; Biomarker; INFILTRATING LYMPHOCYTES; NEOADJUVANT CHEMOTHERAPY; FREE SURVIVAL; TRASTUZUMAB; TRIAL;
D O I
10.1016/j.ctrv.2016.09.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is well recognized that the immune system plays an essential role in tumor defense. The presence of tumor-infiltrating lymphocytes reflects an individual immunological response. In early breast cancer, the presence of TILs is associated with a more favorable outcome and response to therapy. In this review, we describe how TILs are assessed. Also, we discuss their role as prognostic and predictive biomarker in the neoadjuvant and adjuvant settings as well as in residual disease. Moreover, we discuss the possible implementation of TILs in daily clinical practice as well as in future clinical trials in order to fine tune prognosis and improve treatments. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:205 / 207
页数:3
相关论文
共 22 条
[1]   LYMPHOCYTE INFILTRATES AS A PROGNOSTIC VARIABLE IN FEMALE BREAST-CANCER [J].
AALTOMAA, S ;
LIPPONEN, P ;
ESKELINEN, M ;
KOSMA, VM ;
MARIN, S ;
ALHAVA, E ;
SYRJANEN, K .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) :859-864
[2]   Molecular Pathways: Involvement of Immune Pathways in the Therapeutic Response and Outcome in Breast Cancer [J].
Andre, Fabrice ;
Dieci, Maria V. ;
Dubsky, Peter ;
Sotiriou, Christos ;
Curigliano, Giuseppe ;
Denkert, Carsten ;
Loi, Sherene .
CLINICAL CANCER RESEARCH, 2013, 19 (01) :28-33
[3]   Concurrent adjuvant systemic therapy and accelerated radiotherapy in triple-negative breast cancer: A feasibility trial. [J].
Ashworth, Rene Eleanor ;
Adams, Sylvia ;
Fenton-Kerimian, Maria ;
Sacris, Erlinda ;
Speyer, James L. ;
Leichman, Cynthia G. ;
Janosky, Maxwell Dale ;
Guo, Songchuan ;
Goldberg, Judith D. ;
Novik, Yelena ;
Formenti, Sylvia .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[4]   Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer [J].
Brown, Jason R. ;
Wimberly, Hallie ;
Lannin, Donald R. ;
Nixon, Christian ;
Rimm, David L. ;
Bossuyt, Veerle .
CLINICAL CANCER RESEARCH, 2014, 20 (23) :5995-6005
[5]   Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].
Cortazar, Patricia ;
Zhang, Lijun ;
Untch, Michael ;
Mehta, Keyur ;
Costantino, Joseph P. ;
Wolmark, Norman ;
Bonnefoi, Herve ;
Cameron, David ;
Gianni, Luca ;
Valagussa, Pinuccia ;
Swain, Sandra M. ;
Prowell, Tatiana ;
Loibl, Sibylle ;
Wickerham, D. Lawrence ;
Bogaerts, Jan ;
Baselga, Jose ;
Perou, Charles ;
Blumenthal, Gideon ;
Blohmer, Jens ;
Mamounas, Eleftherios P. ;
Bergh, Jonas ;
Semiglazov, Vladimir ;
Justice, Robert ;
Eidtmann, Holger ;
Paik, Soonmyung ;
Piccart, Martine ;
Sridhara, Rajeshwari ;
Fasching, Peter A. ;
Slaets, Leen ;
Tang, Shenghui ;
Gerber, Bernd ;
Geyer, Charles E., Jr. ;
Pazdur, Richard ;
Ditsch, Nina ;
Rastogi, Priya ;
Eiermann, Wolfgang ;
von Minckwitz, Gunter .
LANCET, 2014, 384 (9938) :164-172
[6]   Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers [J].
Denkert, Carsten ;
von Minckwitz, Gunter ;
Brase, Jan C. ;
Sinn, Bruno V. ;
Gade, Stephan ;
Kronenwett, Ralf ;
Pfitzner, Berit M. ;
Salat, Christoph ;
Loi, Sherene ;
Schmitt, Wolfgang D. ;
Schem, Christian ;
Fisch, Karin ;
Darb-Esfahani, Silvia ;
Mehta, Keyur ;
Sotiriou, Christos ;
Wienert, Stephan ;
Klare, Peter ;
Andre, Fabrice ;
Klauschen, Frederick ;
Blohmer, Jens-Uwe ;
Krappmann, Kristin ;
Schmidt, Marcus ;
Tesch, Hans ;
Kuemmel, Sherko ;
Sinn, Peter ;
Jackisch, Christian ;
Dietel, Manfred ;
Reimer, Toralf ;
Untch, Michael ;
Loibl, Sibylle .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) :983-991
[7]   Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer [J].
Denkert, Carsten ;
Loibl, Sibylle ;
Noske, Aurelia ;
Roller, Marc ;
Mueller, Berit Maria ;
Komor, Martina ;
Budczies, Jan ;
Darb-Esfahani, Silvia ;
Kronenwett, Ralf ;
Hanusch, Claus ;
von Toerne, Christian ;
Weichert, Wilko ;
Engels, Knut ;
Solbach, Christine ;
Schrader, Iris ;
Dietel, Manfred ;
von Minckwitz, Gunter .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :105-113
[8]   Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study (vol 25, pg 611, 2015) [J].
Dieci, M. V. ;
Criscitiello, C. ;
Goubar, A. ;
Viale, G. ;
Conte, P. ;
Guarneri, V. ;
Ficarra, G. ;
Mathieu, M. C. ;
Delaloge, S. ;
Curigliano, G. ;
Andre, F. .
ANNALS OF ONCOLOGY, 2015, 26 (07) :1518-1518
[9]   Immune Regulation of Cancer [J].
Disis, Mary L. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) :4531-4538
[10]   The three Es of cancer immunoediting [J].
Dunn, GP ;
Old, LJ ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :329-360